Hillard Lazarus
Hematology & Oncology · Cleveland, OHNPI 1255351920
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,493,248 of the $2,044,800 with a category attached, or 73.0%. Partner Therapeutics, Inc. accounts for 69.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $375,338 and has fallen 72.5% since, to $103,113 in 2025. Among hematology & oncology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 639 payments — averaging $3200.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Partner Therapeutics, Inc.$1.4M
- Seagen Inc.$180K
- Jazz Pharmaceuticals Inc.$157K
- E.r. Squibb & Sons, L.L.C.$73K
- Bristol Myers Squibb$43K
- Amgen$41K
- plus $133K from 12 others
What the payments were for
- Consulting fees$1,493,24873%
- Speaking & faculty fees$471,20923%
- Travel & lodging$69,4493%
- Food & beverage$10,7951%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Partner Therapeutics, Inc. | 83 | $1,416,870 |
| Seagen Inc. | 177 | $179,941 |
| Jazz Pharmaceuticals Inc. | 130 | $157,219 |
| E.r. Squibb & Sons, L.L.C. | 60 | $72,997 |
| Bristol Myers Squibb | 17 | $43,148 |
| Amgen | 50 | $41,200 |
| AstraZeneca(2 entities) | 39 | $40,410 |
| CSL Behring | 12 | $23,785 |
| Pfizer | 19 | $18,639 |
| Teva Pharmaceuticals USA, Inc. | 9 | $17,220 |
| Pharmacyclics LLC, An Abbvie Company | 23 | $16,761 |
| Genentech USA, Inc. | 8 | $7,654 |
| Johnson & Johnson | 3 | $2,824 |
| Kadmon Pharmaceuticals LLC | 3 | $2,516 |
| Novartis | 1 | $1,965 |
| Sanofi | 1 | $1,300 |
| Gilead | 3 | $252 |
| Astellas Pharma US Inc | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,044,800 in reported general payments places this provider in the 95th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Cleveland
- Ronald BukowskiCleveland$594K
- Balazs HalmosCleveland$568K
- Jorge GarciaCleveland$513K
- Bachar DerghamCleveland$387K
- Brian HillCleveland$316K
- Dale ShepardCleveland$314K
- Sakti ChakrabartiCleveland$301K
- Keith McCraeCleveland$215K
- Megan KruseCleveland$166K
- Afshin DowlatiCleveland$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.